fig5

Extended cycles of adjuvant temozolomide improves survival outcomes in glioblastoma: a retrospective analysis

Figure 5. OS (A) and PFS (B) for patients with solitary GBM, and OS (C) and PFS (D) for patients with multiple GBM in the treatment group.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/